Product
Supplier
Encyclopedia
Inquiry
Home > Pharmaceutical Intermediates > Antineoplastics > Sunitinib malate for Sale > Sunitinib Malate CAS341031-54-7 supply high quality best service fast delivery
Sunitinib Malate CAS341031-54-7 supply high quality best service fast delivery buy - large image1
Sunitinib Malate CAS341031-54-7 supply high quality best service fast delivery buy - image1
Sunitinib Malate CAS341031-54-7 supply high quality best service fast delivery buy - image2
Sunitinib Malate CAS341031-54-7 supply high quality best service fast delivery buy - image3
Sunitinib Malate CAS341031-54-7 supply high quality best service fast delivery buy - image4
Sunitinib Malate CAS341031-54-7 supply high quality best service fast delivery buy - image5
Sunitinib Malate CAS341031-54-7 supply high quality best service fast delivery buy - image6

Sunitinib Malate CAS341031-54-7 supply high quality best service fast delivery

2 Inquiries

Unit Price:

$2.53/KG EXW

Get Latest Price
CAS No.:

341031-54-7

Grade:

Pharmaceutical Grade

Content:

99.6%

Brand:

Million

Packaging:

25kg/Cardboard Drum

Price valid (until):

2030-03-24

Company Type:
Manufactory
Location:
China
Qualification:
Main Products:

Avanafil,Tirzepatide,Semaglutide,Pregabalin,Nootropics,MT2

  • Product Description

  • Seller Information

  • Inquiry History

  • Description

    Shop S-Acetyl-L-glutathione CAS3054-47-5 supply-Detailed Image 1

    -Product description-

    General:Sunitinib malate is a novel oral multi-target anti-tumor drug, belonging to the category of multi-target tyrosine kinase inhibitors. It has dual anti-tumor and anti angiogenic effects and holds a core position in the treatment of renal cell carcinoma and gastrointestinal stromal tumors.

    Product introduce:Sunitinib Malate (SU11248) is a multi-target RTK inhibitor that acts on VEGFR2 (Flk-1) and PDGFR β, It will inhibit the activity of c-Kit. Can effectively inhibit Ire1 α The self phosphorylation of increases death receptor and mitochondrial dependent cell apoptosis.

    Function:Sunitinib plays a therapeutic role by preventing tumor cells from obtaining the necessary blood and nutrients for growth. Clinical trials have shown that this drug can slow down the growth rate of gastrointestinal stromal tumors and reduce the size of renal cell tumors.

    Origin:Developed by Pfizer in the United States, it has a dual anti-tumor effect and is the only therapeutic drug that breaks through the 2-year survival period of advanced renal cell carcinoma. In February 2006, sunitinib malate was launched in the United States, which was the first anti-cancer drug approved by the US FDA to treat both diseases simultaneously.

    Items Specifications

    Common Name

    Sunitinib malate

    CAS Number

    341031-54-7

    MF

    C26H33FN4O7

    M.W.

    532.57


    Shop S-Acetyl-L-glutathione CAS3054-47-5 supply-Detailed Image 2

    -Why Choose Us?-

    1、We have excellent research and development capabilities and complete industrial bases with international quality management system.
    2、We have worked with reputable customers,like METROCHEM API PVT LTD;BDR LIFESCIENCES PVT.LTD;SRINI CHEM;EVA PHARMA;PHARMAFFILIATES ANALYTICS&SYNTHETICS(P)LTD;....from India,Egypt,Canada...
    3、We adheres to the business philosophy of "dedication and innovation", insist on pioneering and innovating, constantly improve the quality system, and vigorously train technical and management talents to build an elite team and serves customers better.

    -Packing&Shipping-

    Shop 1-(1-aminoethyl)cyclopropanol CAS1778734-58-9-Detailed Image 3

    Shipping choices

    By EMS/E-packet

    By DHL/TNT/FeDex

    By air

    By sea

    Suitable quatity

    Under 5KG

    Under 50KG

    Under 100KG

    More than 100KG

    Shipping time

    7-15 Days

    3-10 Days

    5-15 Days

    10-15 Days

    Shipping cost

    A bit high

    High

    Low

    Lower

    Service

    Door To Door

    To airport

    To port

    -Company profile-

    Shop Sunitinib Malate CAS341031-54-7 supply-Detailed Image 4

    Shop Sunitinib Malate CAS341031-54-7 supply-Detailed Image 5

    About us:

    Founded in 2012, Jinan Million Pharmaceutical Co., Ltd (Jinan Milin Pharmaceutical Co., Ltd) is a modern pharmaceutical enterprise guided by innovation. Million pharm has excellent research and development capabilities and complete industrial bases with international quality management system. It is dedicated to the research, development, production and customization of pharmaceuticals and advanced pharmaceutical intermediates.
     
        Jinan Million Pharmaceutical Co., Ltd has been focusing on the research of Cerebro-cardiovascular drugs, Central nervous system drugs, Anti-cancer drugs, Antibacterial drugs and others for 12 years; the products are: Apixabn, Lurasidon, Bexagliflozin, Votioxitin, Loxo-292/Selpercatinib, Indacaterl, Baricitin and intermediates. Million has worked with reputable customers, like METROCHEM API PVT LTD; BDR LIFESCIENCES PVT.LTD; SRINI CHEM; EVA PHARMA; PHARMAFFILIATES ANALYTICS & SYNTHETICS (P) LTD; ....from India, Egypt, Canada...

       

       Jinan Million Pharmaceutical Co., Ltd has a 1,500㎡ R&D center in the Zhongguancun E Valley (Qihe) Incubator, equipped with complete test equipment, such as high-performance liquid chromatography, nuclear magnetic resonance spectrometer, liquid chromatography mass spectrometer, automatic polarimeter, etc., which can meet the needs of various  laboratory scale tests in different conditions. The pilot workshop is equipped with 50L and 100L glass reactors, high and low temperature equipment, etc., which can support organic chemical reactions at -100°C or 200°C. In addition, Million has a production site in Linyi city with many independent production lines, such as: production line of Apixabn intermediate 20 tons/year, production line of Lurasidon intermediate 10 tons/year, which can meet the commercial production of various products.
           

       The technical team is composed of high-level talents in major of pharmacy, bio-pharmaceutical or chemical synthesis, of which 10% has doctor’s degree and 15% has master’s degree. The team members are young and energetic with innovative spirit and willing to overcome obstacles.
         

       Jinan Million Pharmaceutical Co., Ltd adheres to the business philosophy of "dedication and innovation", insists on pioneering and innovating, constantly improves the quality system, and vigorously trains technical and management talents to build an elite team and serves customers better. Looking forward to cooperate with you for joint development and common progress.

    -Certification-

    Shop Sunitinib Malate CAS341031-54-7 supply-Detailed Image 6

    Basic Info
    Product Name:

    Sunitinib malate

    Other Name:

    Butanedioic acid,2-hydroxy-,(2S)-,compd. with N-[2-(diethylamino)ethyl]-5-[(Z)-(5-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide (1:1);Butanedioic acid,hydroxy-,(2S)-,compd. with N-[2-(diethylamino)ethyl]-5-[(Z)-(5-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide (1:1);1H-Pyrrole-3-carboxamide,N-[2-(diethylamino)ethyl]-5-[(Z)-(5-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl]-2,4-dimethyl-,(2S)-hydroxybutanedioate (1:1);Sunitinib malate;SU 011248;SU 11248;Sutent;Sunitinib L-malate;Sunitinib L-malate

    CAS No.:

    341031-54-7

    Molecular Formula:

    C22H27FN4O2.C4H6O5

    Molecular Weight:

    532.566

    Exact Mass:

    532.233337

    EC Number:

    1308068-626-2

    HScode:

    29337900

    Categories:

    Antineoplastics

    Characteristics
    PSA:

    172.06000

    XLogP3:

    2.77040

    Density:

    1.3600 g/mL at 25 °C(lit.)

    Melting Point:

    189-191°C

    Boiling Point:

    572.1ºC at 760mmHg

    Flash Point:

    163 °F

    Refractive Index:

    n20/D 1.455(lit.)

    Water Solubility:

    DMSO: >10mg/mL

    Storage Conditions:

    Store at +4°C

    Hazard Identification

    Classification of the substance or mixture

    Reproductive toxicity, Category 1B

    Specific target organ toxicity – repeated exposure, Category 1

    GHS label elements, including precautionary statements

    Pictogram(s)
    Signal word

    Danger

    Hazard statement(s)

    H360 May damage fertility or the unborn child

    H372 Causes damage to organs through prolonged or repeated exposure

    Precautionary statement(s)
    Prevention

    P203 Obtain, read and follow all safety instructions before use.

    P280 Wear protective gloves/protective clothing/eye protection/face protection/hearing protection/...

    P260 Do not breathe dust/fume/gas/mist/vapours/spray.

    P264 Wash ... thoroughly after handling.

    P270 Do not eat, drink or smoke when using this product.

    Response

    P318 IF exposed or concerned, get medical advice.

    P319 Get medical help if you feel unwell.

    Storage

    P405 Store locked up.

    Disposal

    P501 Dispose of contents/container to an appropriate treatment and disposal facility in accordance with applicable laws and regulations, and product characteristics at time of disposal.

    Other hazards which do not result in classification

    no data available

    Handling and Storage

    Precautions for safe handling

    Handling in a well ventilated place. Wear suitable protective clothing. Avoid contact with skin and eyes. Avoid formation of dust and aerosols. Use non-sparking tools. Prevent fire caused by electrostatic discharge steam.

    Conditions for safe storage, including any incompatibilities

    Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials.

  • Seller Information
    Business Type:

    Manufactory

    Main Products:

    Avanafil,Tirzepatide,Semaglutide,Pregabalin,Nootropics,MT2

    Location:

    Room 1-2208, Lianhecaifu Square, No2177, Tianchen Road, Gaoxin District, Jinan City, Shandong Province, China

    Payment Terms:

    L/C,100% TT in advance

    Average lead Time:

    3

    Total Annual Revenue:

    $1 million-$2.5 million

    Total Employees:

    11-50

    Year of Establishment:

    2012

    Certifications:

    business license

    Founded in 2012, Jinan Million Pharmaceutical Co., Ltd (Jinan Milin Pharmaceutical Co., Ltd) is a modern pharmaceutical enterprise guided by innovation. Million pharm has excellent research and development capabilities and complete industrial bases with international quality management system. It is dedicated to the research, development, production and customization of pharmaceuticals and advanced pharmaceutical intermediates.
     
    Jinan Million Pharmaceutical Co., Ltd has been focusing on the research of Cerebro-cardiovascular drugs, Central nervous system drugs, Anti-cancer drugs, Antibacterial drugs and others for 12 years; the products are: Apixaban, Lurasidone, Bexagliflozin, Votioxitine, Loxo-292/Selpercatinib, Baricitinib and intermediates. Million has worked with reputable customers, like METROCHEM API PVT LTD; BDR LIFESCIENCES PVT.LTD; INCETPAT PHARM; SRINI CHEM; EVA PHARMA; PHARMAFFILIATES ANALYTICS & SYNTHETICS (P) LTD; ....from India, Egypt, Canada...



    Jinan Million Pharmaceutical Co., Ltd has a 1,500㎡ R&D center in the Zhongguancun E Valley (Qihe) Incubator, equipped with complete test equipment, such as high-performance liquid chromatography, nuclear magnetic resonance spectrometer, liquid chromatography mass spectrometer, automatic polarimeter, etc., which can meet the needs of various  laboratory scale tests in different conditions. The pilot workshop is equipped with 50L and 100L glass reactors, high and low temperature equipment, etc., which can support organic chemical reactions at -100°C or 200°C. In addition, Million has a production site in Linyi city with many independent production lines, such as: production line of Apixabn intermediate 20 tons/year, production line of Lurasidon intermediate 10 tons/year, which can meet the commercial production of various products.
     
    The technical team is composed of high-level talents in major of pharmacy, bio-pharmaceutical or chemical synthesis, of which 10% has doctor’s degree and 15% has master’s degree. The team members are young and energetic with innovative spirit and willing to overcome obstacles.
     
    Jinan Million Pharmaceutical Co., Ltd adheres to the business philosophy of "dedication and innovation", insists on pioneering and innovating, constantly improves the quality system, and vigorously trains technical and management talents to build an elite team and serves customers better. Looking forward to cooperate with you for joint development and common progress.

  • Inquiry History
    2 Inquiries
    Country Product Purchase Quantity Date Posted
    India

    Sunitinib Malate ( USP Grade )

    50.00 KG Aug 23, 2024
    Russia

    Sunitinib Malate

    1 KG Nov 28, 2024
    Post an enquiry for this product
pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.